by In2Pharma | Nov 28, 2019 | News
Europe A new Commission Regulation has been published ((EU) 2019/1901) amending Regulation (EC) No 1881/2006 regarding maximum levels of citrinin in food supplements based on rice fermented with red yeast Monascus Purpureus. The maximum level of citrinin has been set...
by In2Pharma | Feb 28, 2019 | News
European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...
by In2Pharma | Dec 17, 2018 | News
EMA EMA published an updated Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’. The annex contains a list of all excipients known to have a recognised action or effect that need to be...
